Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 84

· covers 07 a 09/02/2026

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

ANS PUBLIC CONSULTATION No. 167, OF FEBRUARY 6, 2026.

Art. 1° A Public Consultation is hereby opened, with a period of 20 (twenty) days, from February 10, 2026 to March 1, 2026, based on item III, §11, of art. 10, of Law No. 9,656/1998 and on art. 26, of RN 555/2022, for the submission of criticisms and suggestions regarding the preliminary recommendations contained in UAT No. 186 – Encorafenibe, UAT No. 189 – Osimertinibe and UAT No. 190 – Talazoparibe.

ANS news

ANS holds meeting with the board of Unimed-Rio

Regular payment to cooperative physicians and full operation of the Barra da Tijuca hospital were the subjects discussed

Decisions of the 2nd Extraordinary Meeting of the Board of Directors of 2026

Decisions:

00:03:57 – ITEM 1 DIPRO – Decision on the proposed update of the List of Health Procedures and Events (Rol). Technical Note of Preliminary Recommendation regarding Technical Analysis Units (UATs) 186, 189 and 190. Opening of public consultation and public hearing.

00:17:12 – ITEM 2 DIPRO – Decision on the proposed update of the List of Health Procedures and Events (Rol). Outcome of the Public Consultation. Technical Note of Final Recommendation regarding UAT 172. Approval of the proposed normative resolution.

00:28:18 – ITEM 3 DIPRO – Decision on the proposed suspension of the deadline for completing the analysis regarding UAT 171 – Inclisirana, for the treatment of primary hypercholesterolemia or mixed dyslipidemia in patients with atherosclerotic disease.

Open public consultations

There are no open public consultations.

Scheduled public hearings

  • CP 167. Subject: CP opened to collect criticisms and suggestions regarding the preliminary recommendations contained in UAT No. 186 – Encorafenibe, UAT No. 189 – Osimertinibe and UAT No. 190 – Talazoparibe. Deadline: Feb 10 to Mar 1.

Open public calls for input

  • A Public Call for Input (TPS) is hereby opened, intended for receiving suggestions on the priority supplementary health topics that will inform the composition of the 2026-2028 Regulatory Agenda of the Agência Nacional de Saúde Suplementar (ANS). Extension: February 27, 2026.

Open public calls

No updates.

Other news

– No updates.

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.